Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of May 28, 2015 06:05 PM ET

 Add to portfolio

$263.72 USD

-0.95 (-0.36%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Apr 30, 2015

Total Return %* Percentile Rank Objective
YTD 9.62 13
3 months 2.84 83
6 months 14.99 12
1 Year 48.11 1
3 Year 40.96 1
5 Year 31.79 1
10 Year 18.87 3

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 41.21
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 4/30/2015 13,863.74
%Turnover 4/30/2015 35.00

Risk

3 Year 5 Year 10 Year
Beta 0.88 0.98 0.79
Alpha 25.49 17.27 12.29
R Squared 0.16 0.37 0.34
Std. Dev. 21.17 21.04 19.99
Sharpe 2.07 1.64 2.00

Sector / Country Weightings

As of 4/30/2015 % of Portfolio
Health 61.25
Services 18.69
Other 12.18
Industrial Cyclical 7.62
Technology 0.26

Portfolio Holdings

Top Equity Holdings
(As of 2/28/2015)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.89 1,047.64
BIOGEN IDEC INC 7.05 935.72
CELGENE CORP 6.11 810.70
VERTEX PHARMACEUTICALS IN 4.35 577.47
ALEXION PHARMACEUTICALS I 3.65 484.92
REGENERON PHARMACEUTICALS 3.53 468.50
BIOMARIN PHARMACEUTICAL 2.44 324.11
MEDIVATION INC 2.26 299.60
RECEPTOS INC 2.19 290.26

Stock Holding % of Net Assets

As Of 2/28/2015
Total Issues 192
Avg. P/E 49.50
Avg. P/Book 6.08
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 36,369

Allocation

% of Portfolio
Large Growth 9.72
Large Value 0.00
Small Growth 17.08
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 1.48
Intermediate Bond 16.42
Foreign Bond 0.00
High Yield Bond 0.00